Search results
US Senate committee investigates pricing of Novo's Ozempic and Wegovy By Reuters
Investing.com· 1 day agoCommittee on Health, Education, Labor and Pensions, sent a letter to Novo's CEO seeking more...
Don’t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List
InvestorPlace· 13 hours agoBlue-chip growth stocks are all around us. Income investors seeking dividends favored blue-chip...
AstraZeneca's £18.7m boss Soriot bounces back as pharma giant reveals 18% sales growth
Evening Standard via Yahoo Finance· 13 hours agoThey’re up 10% this year and have quadrupled in value, adding almost £150 billion to the company’s...
How one state is trying to make weight loss drugs cheaper
NBC Universal via AOL· 1 day agoWeight loss drugs aren't covered by insurance for North Carolina's state employees. The state is...
Vertex has top orphan drug in the pipeline, as pharma eyes shiny obesity drugs: report
FierceBiotech· 2 days agoThe med has a net present value of $5.801 billion, with $1.26 billion in sales expected by 2028....
AstraZeneca leaps after smashing first-quarter forecasts
Reuters via Yahoo News· 17 hours agoOncology, the Anglo-Swedish drugmaker's top business, delivered a 26% jump in first-quarter sales to...
...HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for...
Benzinga· 2 days agoHOOKIPA Pharma Inc. HOOK ‘HOOKIPA'))), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the
Cigna to offer Humira rivals with $0 copay at specialty pharmacy By Reuters
Investing.com· 3 hours agoCigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers...
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the...
FOX 59 Indianapolis· 16 hours agoMedivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative...
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 1 day agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...